Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 200880-40-6
2. 1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) Sodium Salt
3. Dmpg-na, R-
4. Sodium;2,3-dihydroxypropyl [(2r)-2,3-di(tetradecanoyloxy)propyl] Phosphate
5. Q24r39ny7r
6. L-dimyristoylphosphatidylglycerol (sodium Salt)
7. Dimyristoylphosphatidylglycerol, L- (sodium Salt)
8. Dimyristoylphosphatidylglycerol Sodium Salt
9. 1,2-dimyristoyl-sn-glycero-3-phospho-(1'-rac-glycerol)(sodium Salt)
10. 1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol)
11. Sodium 1,2-dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol))
12. Dmpg-na, L-
13. 1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) (sodium Salt)
14. 1,2-dimyristoyl-sn-glycero-3-phospho-sn-glycerol Sodium Salt
15. Dmpg-na
16. Unii-q24r39ny7r
17. Dmpg Sodium Salt
18. Dtxsid60173906
19. Mfcd00056649
20. Akos037647863
21. As-75085
22. Bp-26310
23. Tetradecanoic Acid, (1r)-1-[[[(2,3-dihydroxypropoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl Ester, Sodium Salt (1:1)
24. D3946
25. D90239
26. 1,2-dimyristoyl-sn-glycero-3-phosphorylglycerol
27. A926094
28. J-003477
29. Q27286906
30. 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol, Sodium Salt
31. 1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) Sodium Salt, >=99%
32. Sodium (r)-2,3-bis(tetradecanoyloxy)propyl 2,3-dihydroxypropyl Phosphate
33. Sodium 2,3-dihydroxypropyl [(2r)-2,3-di(tetradecanoyloxy)propyl] Phosphate
34. 1,2-dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (sodium Salt)
35. 1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) Sodium Salt, >=98.0% (tlc)
36. 3-[[(1-o,2-o-dimyristoyl-l-glycerol-3-o-yl)(sodiooxy)phosphinyl]oxy]propane-1,2-diol
37. (2,3-dihydroxy-1-((1-(((s)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl)oxy)-1-oxo-1l5-tetradecyl)oxy)propyl)phosphonic Acid
38. Sodium (2r)-1-[(2,3-dihydroxypropyl Phosphonato)oxy]-3-(tetradecanoyloxy)propan-2-yl Tetradecanoate
39. Tetradecanoic Acid, (1r)-1-((((2,3- Dihydroxypropoxy)hydroxyphosphinyl)oxy)methyl)-1,2-ethanediyl Ester, Monosodium Salt
40. Tetradecanoic Acid, (1r)-1-((((2,3-dihydroxypropoxy)hydroxyphosphinyl)oxy)methyl)-1,2-ethanediyl Ester, Monosodium Salt
| Molecular Weight | 688.8 g/mol |
|---|---|
| Molecular Formula | C34H66NaO10P |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 36 |
| Exact Mass | 688.42912958 g/mol |
| Monoisotopic Mass | 688.42912958 g/mol |
| Topological Polar Surface Area | 152 Ų |
| Heavy Atom Count | 46 |
| Formal Charge | 0 |
| Complexity | 743 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt, including repackagers and relabelers. The FDA regulates 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt supplier is an individual or a company that provides 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt active pharmaceutical ingredient (API) or 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt finished formulations upon request. The 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt suppliers may include 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt API manufacturers, exporters, distributors and traders.
1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt GMP manufacturer or 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt GMP API supplier for your needs.
A 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt CoA (Certificate of Analysis) is a formal document that attests to 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt's compliance with 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt specifications and serves as a tool for batch-level quality control.
1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt CoA mostly includes findings from lab analyses of a specific batch. For each 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt may be tested according to a variety of international standards, such as European Pharmacopoeia (1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt EP), 1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1,2-Dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), sodium salt USP).
LOOKING FOR A SUPPLIER?
